ACLX
Arcellx Inc
NASDAQ: ACLX · HEALTHCARE · BIOTECHNOLOGY
$115.07
+0.00% today
Updated 2026-04-28
Market cap
$6.73B
P/E ratio
—
P/S ratio
302.04x
EPS (TTM)
$-4.07
Dividend yield
—
52W range
$48 – $115
Volume
2.8M
Arcellx Inc (ACLX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.86M | $-18.77M | $-28.66M | $-54.24M | $-99.30M | $207.57M | $-83.47M | $-210.26M |
| Capital expenditures | $479000.00 | $3.83M | $888000.00 | $5.78M | $2.28M | $21.43M | $13.43M | $2.33M |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $66000.00 | $136000.00 | $1.05M | $6.75M | $21.54M | $41.79M | $61.09M | $77.89M |
| Free cash flow | $-7.34M | $-22.60M | $-29.55M | $-60.02M | $-101.58M | $186.15M | $-96.90M | $-212.59M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $119.12M | — | $271.40M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |